Neuromed Pharmaceuticals Inc. closed a $53.3 million Series E financing, bringing the company's running total of venture capital raised to date to more than $126 million. (BioWorld Today)

Neuromed Pharmaceuticals Inc. closed a $53.3 million Series E financing, bringing the company's running total of venture capital raised to date to more than $126 million. (BioWorld Today)